Anon.: "Betaferon", , 8 February 2010 (2010-02-08), XP002677736, Retrieved from the Internet: URL:http://www.pharmaline.co.il/images/new sletterregistration/bayer/betaferondoctor. pdf [retrieved on 2012-06-13] (B1)

Anon.: "Instructions for use: Avostartgrip Titration Kit", Biogen Idec Inc. , February 2012 (2012-02), XP002677737, Retrieved from the Internet: URL:http://www.avonex.com/pdfs/guides/Avos tartgrip_IFU.pdf [retrieved on 2012-06-13] (B1)

Anon.: "Medication Guide Appendix: Instructions for Preparing and Giving a Dose with an Avonex Prefilled Syringe", Biogen Idec Inc. , August 2010 (2010-08), XP002677734, Retrieved from the Internet: URL:http://www.avonex.com/pdfs/guides/Liqu id_appendix_I61023.pdf [retrieved on 2012-06-13] (B1)

BRANDES D W ET AL: "Alleviating flu-like symptoms with dose titration and analgesics in MS patients on intramuscular interferon beta-1a therapy: A pilot study", CURRENT MEDICAL RESEARCH AND OPINION, INFORMA HEALTHCARE, GB, vol. 23, no. 7, 1 July 2007 (2007-07-01), pages 1667-1672, XP009160129, ISSN: 0300-7995, DOI: 10.1185/030079907X210741 (B1)

WROE: "Effects of dose titration on tolerability and efficacy of interferon beta-1b in people with multiple sclerosis.", JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 33, no. 3, 1 January 2005 (2005-01-01), pages 309-318, XP55029629, ISSN: 0300-0605 (B1)

HURWITZ B J ET AL: "Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 @?g QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study", CLINICAL THERAPEUTICS, EXCERPTA MEDICA, PRINCETON, NJ, US, vol. 30, no. 6, 1 June 2008 (2008-06-01), pages 1102-1112, XP022938732, ISSN: 0149-2918, DOI: 10.1016/J.CLINTHERA.2008.06.013 [retrieved on 2008-06-01] (B1)

J PHILLIPS ET AL: "A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis", CLINICAL THERAPEUTICS, vol. 26, no. 4, 1 April 2004 (2004-04-01), pages 511-521, XP55029619, ISSN: 0149-2918, DOI: 10.1016/S0149-2918(04)90053-7 (B1)

MATSON M A ET AL: "Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation", CURRENT MEDICAL RESEARCH AND OPINION, INFORMA HEALTHCARE, GB, vol. 27, no. 12, 1 December 2011 (2011-12-01), pages 2271-2278, XP009160128, ISSN: 0300-7995, DOI: 10.1185/03007995.2011.630720 (B1)

Rice G P A; Ebers G C; Lublin F D; Knobler R L: "Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS", Neurology Neurology, vol. 52, no. 9 1 June 1999 (1999-06-01), pages 1893-1895, XP002677735, DOI: 10.1212/WNL.52.9.1893 Retrieved from the Internet: URL:http://www.neurology.org/content/52/9/ 1893.full [retrieved on 2012-06-12] (B1)

FROHMAN ELLIOT ET AL: "Disease-modifying therapy in multiple sclerosis: strategies for optimizing management", NEUROLOGIST, WLLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 8, no. 4, 1 July 2002 (2002-07-01), pages 227-236, XP009160126, ISSN: 1074-7931 (B1)